Athenahealth-backed PatientPop has now raised a total of $75m in funding, after receiving an undisclosed in a round led by Leerink Transformation Partners.

Lilly Asia Ventures, which supplied $30m to help small-molecule therapy developer Terns Pharmaceutical launch last year, has returned for its $80m series B round.

Oxford spinout Argonaut Therapeutics has received $2.6m from JW Pharmaceuticals in return for a 25% stake.

Acera Surgical, a spinout of Washington University in St Louis, has raised an initial $5.1m out of a targeted $10m.

UNC-Chapel Hill has become the latest university to join forces with Deerfield Management and launch a $65m commercialisation fund.

Fujifilm, Olympus and TechMatrix were among the participants in a round that boosted medical imaging technology provider LPixel's funding to $35m altogether.

IU Philanthropic Venture Fund has committed $500,000 to a $2.2m bridge round for Nerx Biosciences, based on research at Indiana University.

Kate Rowley, formerly a director of IP Group with a focus on the healthcare sector, has joined investment firm BioScience Managers.

Institut Pasteur spinout Invectys will use the funding to advance a drug candidate for a type of leukaemia into a phase 2 trial.

The Legend Capital-backed sacral neuromodulation device developer floated in the middle of its range while upping the number of shares in the IPO.